Tenofovir disoproxil fumarate Good Manufacturer supply High Quality 202138-50-9
- Molecular Formula:C19H30N5O10P.C4H4O4
- Molecular Weight:635.522
- Appearance/Colour:almost white crystalline
- Vapor Pressure:2.06E-16mmHg at 25°C
- Melting Point:219oC
- Boiling Point:642.7 °C at 760 mmHg
- Flash Point:342.5 °C
- PSA：269.85000
- Density:1.45 g/cm3
- LogP:3.32860
Tenofovir disoproxil fumarate (202138-50-9) Usage
Tenofovir disoproxil is a prodrug of the acyclic nucleoside phosphonate, tenofovir . Tenofovir is converted by cellular enzymes to tenofovir diphosphate, an obligate chain terminator that inhibits the activity of HIV reverse transcriptase and hepatitis B virus polymerase. Due to its rapid intracellular uptake, the anti-HIV activity of tenofovir disoproxil is reportedly >100-fold greater than that of the negatively charged tenofovir in a T cell line and primary blood lymphocytes.
How to get the best price on Tenofovir disoproxil fumarate?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Tenofovir disoproxil fumarate . You can buy high quality, low price Tenofovir disoproxil fumarate 202138-50-9 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
